69.41

1.94% -1.37

After Hours: 69.41

Solventum Corp (SOLV)

Overview News Price History Discussions Forecast

Solventum Corp stock is traded at $69.41, with a volume of 1.29M. It is down -1.94% in the last 24 hours and down -11.15% over the past month. In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.

Previous Close:

$70.78

Open:

$70

24h Volume:

1.29M

Relative Volume:

1.19

Market Cap:

$12.04B

Revenue:

$8.42B

Net Income/Loss:

$1.52B

P/E Ratio:

7.99

EPS:

8.6871

Net Cash Flow:

$56.00M

1W Performance:

-6.46%

1M Performance:

-11.15%

6M Performance:

-4.55%

1Y Performance:

-8.36%

1-Day Range:

$68.99

$70.44

1-Week Range:

$68.99

$74.22

52-Week Range:

$60.70

$88.20

Solventum Corp Stock (SOLV) Company Profile

Name

Solventum Corp

Sector

Healthcare (1105)

Industry

Medical Instruments & Supplies (58)

Phone

651-733-1110

Address

C/O 3M COMPANY, ST. PAUL

Employee

22,000

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

SOLV's Discussions on Twitter

Compare SOLV vs ISRG, BDX, ALC, RMD, MDLN

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SOLV Solventum Corp	69.41	12.28B	8.42B	1.52B	56.00M	8.6871
ISRG Intuitive Surgical Inc	490.16	176.39B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	167.12	48.34B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	81.33	40.22B	10.40B	980.00M	1.61B	1.9749
RMD Resmed Inc	252.87	37.19B	5.40B	1.49B	1.78B	10.12
MDLN Medline Inc	43.83	35.75B	28.43B	1.16B	1.26B	1.4457

Solventum Corp Stock (SOLV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-26-26	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Jan-20-26	Upgrade	Mizuho	Neutral → Outperform
Dec-02-25	Upgrade	BTIG Research	Neutral → Buy
Oct-01-25	Initiated	UBS	Neutral
Sep-11-25	Initiated	Jefferies	Hold
Jul-15-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jul-01-25	Upgrade	Argus	Hold → Buy
Jun-06-25	Initiated	KeyBanc Capital Markets	Sector Weight
May-19-25	Upgrade	Piper Sandler	Neutral → Overweight
Dec-04-24	Initiated	Mizuho	Neutral
Oct-08-24	Initiated	Stifel	Buy
Oct-07-24	Initiated	Piper Sandler	Neutral
Sep-26-24	Initiated	Wolfe Research	Peer Perform
Sep-05-24	Initiated	BTIG Research	Neutral
Jun-24-24	Initiated	Argus	Hold
May-30-24	Initiated	Goldman	Sell
May-10-24	Initiated	BofA Securities	Neutral
Apr-10-24	Initiated	Morgan Stanley	Equal-Weight
Apr-08-24	Initiated	Wells Fargo	Equal Weight
Apr-02-24	Initiated	Edward Jones	Hold

View All

Solventum Corp Stock (SOLV) Latest News

Mar 05, 2026

Solventum (SOLV) Q4 2025 Adjusted Diluted EPS Reaches $1.57 on 3.5% Organic Sales Growth - Finviz

Mar 05, 2026

Mar 03, 2026

Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch

Mar 03, 2026

Solventum (SOLV) is Among the Highest-Rated Value Stocks: Is It Worth Purchasing? - Bitget

Mar 03, 2026

SOLV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026

Commit To Purchase Solventum At $65, Earn 11.6% Annualized Using Options - Nasdaq

Mar 03, 2026

UBS Adjusts Solventum Price Target to $82 From $79, Maintains Neutral Rating - marketscreener.com

Mar 02, 2026

Solventum’s High-Stakes Restructuring: Profitability Ambitions Face Significant Execution Risks - The Globe and Mail

Mar 02, 2026

Solventum Corporation (SOLV) Stock Analysis: A 21% Upside Potential Amidst Mixed Signals - DirectorsTalk Interviews

Mar 02, 2026

Solventum Corporation $SOLV Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat

Mar 02, 2026

Will Solventum's (SOLV) $1 Billion Buyback and Strong 2025 Earnings Redefine Its Capital Story? - Sahm

Mar 02, 2026

Mar 01, 2026

Solventum Earnings Call Balances Growth With Headwinds - TipRanks

Mar 01, 2026

Solventum Sets Confident Course with Strategic Overhaul and 2026 Guidance - AD HOC NEWS

Mar 01, 2026

SOLV PE Ratio & Valuation, Is SOLV Overvalued - Intellectia AI

Mar 01, 2026

A Look At Solventum (SOLV) Valuation After Earnings Beat Buyback Plan And Growth Guidance - Yahoo Finance

Mar 01, 2026

Andra AP fonden Has $8.04 Million Holdings in Solventum Corporation $SOLV - MarketBeat

Mar 01, 2026

Feb 28, 2026

Solventum Q4 Earnings Call Highlights - MarketBeat

Feb 28, 2026

Is It Time To Reassess Solventum (SOLV) After The 3M Separation? - simplywall.st

Feb 28, 2026

US Bancorp DE Has $31.04 Million Stock Position in Solventum Corporation $SOLV - MarketBeat

Feb 28, 2026

Solventum (NYSE:SOLV) Rating Increased to Buy at Wall Street Zen - MarketBeat

Feb 28, 2026

Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know - The Globe and Mail

Feb 28, 2026

Piper Sandler reiterates Solventum stock rating on revenue growth By Investing.com - Investing.com South Africa

Feb 28, 2026

Feb 27, 2026

Solventum Q4 FY25 slides: organic growth solid despite earnings miss By Investing.com - Investing.com Australia

Feb 27, 2026

Solventum (SOLV) One Off US$1.5b Gain Raises Questions For Bullish Margin Narratives - simplywall.st

Feb 27, 2026

Solventum Corp. stock falls Friday, underperforms market - MarketWatch

Feb 27, 2026

SOLV: BTIG Reiterates 'Buy' Rating with Price Target Unchanged a - GuruFocus

Feb 27, 2026

Solventum Dental Solutions Sales Grow 8.6% in Q4 - Orthodontic Products

Feb 27, 2026

Solventum Corp SEC 10-K Report - TradingView

Feb 27, 2026

Solventum (NYSE:SOLV) Given New $83.00 Price Target at Wells Fargo & Company - MarketBeat

Feb 27, 2026

Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down - TradingView

Feb 27, 2026